Come and hear various perspectives and lessons learned on technology transfer from academic research to entrepreneurship! This panel discussion will feature three women in various roles in the entrepreneurial ecosystem, including a university faculty member and founder, a Vice President of Technology Commercialization at an academic institution, and an intellectual property attorney. We will discuss what the technology transfer process looks like, what we can negotiate and how, common pitfalls, and more. This session is open to all!

Disclaimer: This event may be recorded, and your image and/or voice may be included in that recording. If you are uncomfortable, please be sure to turn off your webcam.  

Program

12:00 p.m. – 12:15 p.m.  Introductions
12:15 p.m. – 12:45 p.m.  Panel Discussion
12:45 p.m. – 1:00 p.m.  Q&A

Speaker Bios

Salwa Ahmed Elgebaly, PhD, Founder and Chief Executive Officer of Nour Heart

Dr. Salwa Ahmed Elgebaly is a cardio-pharmacologist and Founder and Chief Executive Officer of Nour Heart, a company commercializing diagnostic and therapeutic products for the early detection, prevention, and treatment of myocardial ischemia in patients with ischemic heart disease. Dr. Elgebaly has a unique combination of experiences in academia, the pharmaceutical industry, and clinical trials. She is the inventor of 14 US patents and four pending patent applications, including the cardioprotective bioenergetic drug, Cyclocreatine Phosphate (CCrP, Nourexal®), to protect against ischemic injury and prevent the development of heart failure. She is also a former Associate Professor and Director of Surgical Research in the Department of Surgery at the University of Connecticut School of Medicine, where she is currently adjunct faculty. In recognition of her innovative work in the cardiovascular field, Dr. Elgebaly has been elected as a Fellow of the American College of Cardiology (FACC).

Tatiana Litvin-Vechnyak, PhD, Vice President of Technology Commercialization at Georgetown University

Dr. Tatiana Litvin-Vechnyak is the Vice President of Technology Commercialization at Georgetown University, leading technology transfer efforts at the Office of Technology Commercialization and supporting innovation and faculty entrepreneurship. She is a strategic leader and intellectual property (IP) licensing professional with over 18 years of experience in IP protection strategy and due diligence, business development, and licensing of life sciences, physical sciences, and agriculture innovations. Prior to her position at Georgetown University, Dr. Litvin-Vechnyak was the Associate Vice President of Innovation Ventures at Rutgers, the State University of New Jersey, where she led efforts related to technology transfer and new venture formation, as well as management of university IP. She is an active member in various local and national professional organizations, speaks frequently about IP and technology licensing, has taught courses on commercializing innovation at the Rutgers Graduate School of Biomedical Sciences, and has recently joined the Board of Directors for AUTM.

Lee Matovcik, PhD, JD, Patent Attorney

Dr. Lee Matovcik is an IP attorney and scientist, who provides strategic business counsel to biotech and pharmaceutical companies. She blends an early career in medical research and teaching with a legal career, resulting in the ability to build scientific and business relationships that support the development of comprehensive global patent strategies. She began her legal career as an attorney with Finnegan Henderson Farabow Garrett & Dunner LLP in Washington, DC, and subsequently worked at Novartis Pharmaceuticals Corporation, GlaxoSmithKline Vaccines, and Scholar Rock. Prior to her legal work, Dr. Matovcik was an Associate Professor at Yale University School of Medicine, where she led a research laboratory investigating mechanisms of parathyroid hormone secretion, including cell signaling, intracellular trafficking, signal transduction, and second messenger pathways, as well as teaching histology to medical and PhD students.

• Members: Free
• Non-Members*: $10